Mosloflavone

Mosloflavone

SCHEMBL971985

COc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1OC

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.81
POLB P06746 4/20 0.81
MAPT P10636 4/20 0.81
ADORA3 P0DMS8 1/20 0.81
FLT3 P36888 4/20 0.80
CREB1 P16220 2/20 0.79
SLCO2B1 O94956 1/20 0.79
PRSS1 P07477 1/20 0.79
PRSS2 P07478 1/20 0.79
PRSS3 P35030 1/20 0.79
ABCG2 Q9UNQ0 3/20 0.77
ABCB1 P08183 2/20 0.77
RECQL P46063 1/20 0.77
CYP1A1 P04798 2/20 0.76
CYP1B1 Q16678 2/20 0.76
PTPRS Q13332 1/20 0.76
CYP1A2 P05177 1/20 0.76
OPRD1 P41143 1/20 0.76
AURKA O14965 1/20 0.74
KDR P35968 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mosloflavone SCHEMBL29477310 1.00 KDM4E (0.81) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL28660389 0.91 KDM4E (0.81) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL30606765 0.91 KDM4E (0.81) KDM4EPOLBMAPTADORA3FLT3
Cirsimaritin SCHEMBL29459674 0.90 POLB (1.00) KDM4EPOLBMAPTADORA3FLT3
Cirsimaritin SCHEMBL1663486 0.90 POLB (1.00) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL30152130 0.90 ABCB1 (0.81) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL718970 0.90 ABCB1 (0.81) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL15674607 0.90 ABCB1 (0.81) KDM4EPOLBMAPTADORA3FLT3
Baicalein Trimethyl Ether SCHEMBL971297 0.89 ABCB1 (0.80) KDM4EPOLBMAPTADORA3FLT3
SCHEMBL18828144 0.89 FLT3 (0.71) KDM4EPOLBMAPTADORA3FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113736804-B Baical skullcap flavone methoxy transferase gene, recombinant vector and application thereof 上海辰山植物园 2023-09-22 CN claimed
CN-105669625-A 2-substituted benzopyran-4-one compounds and application thereof 中国人民解放军第二军医大学 2016-06-15 CN claimed
EP-4580594-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-07-09 EP disclosed
US-20240299464-A1 BOTANICAL COMPOUNDS, METHODS, AND PROCEDURES FOR MEDICINAL TREATMENT RELATED TO IMMUNOINFLAMMATION, NEUROINFLAMMATION, DEPRESSION, MEMORY, FOCUS, AND NERVE DEGENERATION NGUYEN MINH H (US) 2024-09-12 US disclosed
WO-2024173722-A2 BOTANICAL COMPOUNDS, METHODS, AND PROCEDURES FOR MEDICINAL TREATMENT RELATED TO IMMUNOINFLAMMATION, NEUROINFLAMMATION, DEPRESSION, MEMORY, FOCUS, AND NERVE DEGENERATION NGUYEN MINH H (US) 2024-08-22 WO disclosed
CN-117379469-B Application of rosewood heart wood extract 珠海市食品药品检验所 2024-04-16 CN disclosed
WO-2024046834-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS ANALYTICON DISCOVERY GMBH (DE) 2024-03-07 WO disclosed
EP-4331564-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS Analyticon Discovery GmbH (DE) 2024-03-06 EP disclosed
CN-117379469-A Application of rosewood heart wood extract 珠海市食品药品检验所 2024-01-12 CN disclosed
US-11812774-B2 Composition for browning inhibition and use of same SUNTORY HOLDINGS LIMITED (JP) 2023-11-14 US disclosed
US-11812774-B2 Composition for browning inhibition and use of same SUNTORY HOLDINGS LIMITED (JP) 2023-11-14 US disclosed
CN-104922103-A Application of mosloflavone in preparation of anti hypoxic drugs MA HUIPING 2015-09-23 CN disclosed
CN-104585255-A Mosquito-repelling bactericide LIU XIANGSHANG 2015-05-06 CN disclosed
CN-104586873-A Application of oroxin A in preparation of medicines for treating cancer UNIV SOOCHOW 2015-05-06 CN disclosed
CN-104431901-A Pickling method of Indian trumetflower seeds PU ER MENGYEJIANG AGRICULTURE FOOD DEV CO LTD 2015-03-25 CN disclosed
CN-103622866-B Perfume capable of whitening and preparation method thereof GOLD ONYX PERFUME MINGGUANG CO LTD 2015-03-04 CN disclosed
CN-103622866-A Perfume capable of whitening and preparation method thereof AGATE PERFUME MINGGUANG CO LTD 2014-03-12 CN disclosed
US-7875650-B2 Baicalein analogs; enhances bioavailability of active compounds, especially orally administered compounds, by inhibition of P-glycoprotein 170 (P-gp 170) and/or CYP450 enzyme; 6-Acetoxy-5,7-dihydroxyflavone YALE UNIVERSITY (US) 2011-01-25 US disclosed
US-20070161605-A1 Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring YALE UNIVERSITY (US) 2007-07-12 US disclosed
WO-2005075449-A1 COMPOUNDS AND METHODS TO INCREASE ANTI-P-GLYCOPROTEIN ACTIVITY OF BAICALEIN BY ALKYLATION ON THE A RING YALE UNIVERSITY (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161605-A1 Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring ABCB1, ABCB11, ABCG2 KDM4E 2696/4885POLB 593/4885MAPT 4867/4885
US-11812774-B2 Composition for browning inhibition and use of same MT-CO1, COX6B1, ARG2 KDM4E 1866/4885POLB 1815/4885MAPT 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.